Related Experiment Videos
Behçet's disease: immunopathologic and therapeutic aspects.
Robert Meador1, George Ehrlich, Joan M Von Feldt
1Department of Rheumatology, Hospital of University of Pennsylvania, 3 Ravdin, Suite G, 3400 Spruce Street, Philadelphia, PA, USA.
Current Rheumatology Reports
|January 19, 2002
Summary
Behçet
Area of Science:
- Immunology
- Rheumatology
- Systemic Inflammatory Diseases
Background:
- Behçet's disease (BD) is a chronic systemic inflammatory disorder of unknown cause.
- It is strongly linked to the human leukocyte antigen (HLA) B51.
- Diagnosis relies on recurrent oral ulcerations, as specific lab tests are absent.
Purpose of the Study:
- To provide a comprehensive overview of Behçet's disease.
- To highlight recent advancements in its immunologic aspects.
- To detail current and emerging treatment strategies.
Main Methods:
- Literature review of Behçet's disease.
- Analysis of immunologic associations.
- Summary of therapeutic interventions.
Main Results:
- Behçet's disease presents with recurrent oral ulcers and systemic inflammation.
- The human leukocyte antigen (HLA) B51 is a significant genetic marker.
- Treatment is tailored to disease severity and requires a multidisciplinary approach.
Conclusions:
- Behçet's disease management necessitates a comprehensive understanding of its pathophysiology.
- Latest immunologic insights are crucial for refining treatment protocols.
- A multidisciplinary approach optimizes patient outcomes in Behçet's disease.